| __timestamp | ACADIA Pharmaceuticals Inc. | Geron Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 32748000 | 16758000 |
| Thursday, January 1, 2015 | 90804000 | 17793000 |
| Friday, January 1, 2016 | 186456000 | 18761000 |
| Sunday, January 1, 2017 | 255062000 | 19287000 |
| Monday, January 1, 2018 | 265758000 | 18707000 |
| Tuesday, January 1, 2019 | 325638000 | 20893000 |
| Wednesday, January 1, 2020 | 388661000 | 25678000 |
| Friday, January 1, 2021 | 396028000 | 29665000 |
| Saturday, January 1, 2022 | 369090000 | 43628000 |
| Sunday, January 1, 2023 | 402466000 | 69135000 |
Igniting the spark of knowledge
In the competitive world of biotechnology, effective cost management is crucial for success. Over the past decade, ACADIA Pharmaceuticals Inc. and Geron Corporation have demonstrated contrasting strategies in managing their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, ACADIA's SG&A expenses surged by over 1,100%, peaking at approximately $402 million in 2023. This reflects their aggressive investment in growth and market expansion. In contrast, Geron Corporation maintained a more conservative approach, with a modest increase of around 310% over the same period, reaching nearly $69 million in 2023. This divergence highlights the varied strategies within the biotech sector, where companies must balance innovation with fiscal prudence. As the industry evolves, these insights into cost management offer valuable lessons for emerging biotech firms aiming to navigate the complexities of growth and sustainability.
Who Optimizes SG&A Costs Better? Merck & Co., Inc. or ACADIA Pharmaceuticals Inc.
SG&A Efficiency Analysis: Comparing Takeda Pharmaceutical Company Limited and Geron Corporation
Selling, General, and Administrative Costs: Insmed Incorporated vs ACADIA Pharmaceuticals Inc.
Operational Costs Compared: SG&A Analysis of Pharming Group N.V. and Geron Corporation
Madrigal Pharmaceuticals, Inc. and Geron Corporation: SG&A Spending Patterns Compared
Cost Management Insights: SG&A Expenses for Alpine Immune Sciences, Inc. and ACADIA Pharmaceuticals Inc.
CymaBay Therapeutics, Inc. vs ACADIA Pharmaceuticals Inc.: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing Veracyte, Inc. and ACADIA Pharmaceuticals Inc.
Comparing SG&A Expenses: ACADIA Pharmaceuticals Inc. vs Soleno Therapeutics, Inc. Trends and Insights
Arrowhead Pharmaceuticals, Inc. and Geron Corporation: SG&A Spending Patterns Compared
ImmunityBio, Inc. or Geron Corporation: Who Manages SG&A Costs Better?
Breaking Down SG&A Expenses: Agios Pharmaceuticals, Inc. vs Geron Corporation